Trial intelligence / Profile preview

Theravex in Periodontal Surgery

NCT07430670Recruiting

Sponsor
Complutense University of Madrid
Start
Feb 2026
Primary completion
Jul 2027
Modality
SOLN (Solution)
Countries
1
01

Overview

Randomised, double-blind trial of Theravex Total Oral Care in gingival recession (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: Recession depth reduction at 12 months. Started Feb 2026; status: recruiting.

02

Drugs

Theravex Total Oral Care
03

Conditions

gingival recession

Beyond the preview

Go deeper on NCT07430670.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07430670.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call